LOGO
LOGO

Why It's Time To Keep A Close Eye On OCUL

By RTTNews Staff Writer   ✉  | Published:  | Google News Follow Us  | Join Us
eye 11022026 lt

Our eyes are not just windows to the soul - they can also provide clues about our overall health. For instance, a routine eye scan may even help predict the risk of stroke. At the same time, the eyes are susceptible to hundreds of different diseases. According to the World Health Organization, more than 2.2 billion people worldwide experience some form of vision impairment or blindness. Aging is a significant risk factor for eye disorders, and one such condition is macular degeneration. Also called age-related macular degeneration (AMD), it is a progressive eye disease for which there is currently no cure, and it exists in two forms: wet and dry.

The company we are profiling today is Ocular Therapeutix Inc. (OCUL), which is developing a treatment for wet AMD.

Subscribe to continue reading the article.
This article is available exclusively to RTT Biotech Investor and Intelligent Investor subscribers. Subscribe with a RTTNews subscription.
Start Free Trial
FREE 7-Day Trial - No Payment Required
Already subscribed? Sign in

For comments and feedback contact: editorial@rttnews.com

Global Economics Weekly Update - Jun 01 - Jun 05, 2026

June 05, 2026 16:18 ET
A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.

RELATED NEWS
Latest Updates on COVID-19